TJRBiosciences is a biopharmaceutical company that focuses on developing innovative therapies for cancer patients. Their two flagship products are the next-generation Bcr-Abl allosteric inhibitor TGRX- with a novel mechanism for the treatment of chronic myelogenous leukemia (CML), and the third-generation ALK inhibitor TGRX- for the treatment of non-small cell lung cancer (NSCLC) 1. They also have a partnering program for interested parties 2.
However, if you have any specific questions about their products or services, I’d be happy to help you find that information.
However, if you have any specific questions about their products or services, I’d be happy to help you find that information.
Employees: 11-50
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | HONGTAI Ap... | apluscap.c... |
Mentions in press and media 1
| Date | Title | Description |
| - | Shenzhen TargetRx | “Taj-sui” |